Nebius Group N.V.: COO Nave Ophir sold 500,000 shares

What happened

• Nave Ophir, chief operating officer and director, sold 500,000 Nebius Group N.V. shares in multiple open-market transactions on Oct 5, 2026, for total proceeds of $117,765,467. The sales were reported on a Form 4 filed Oct 6, 2026.
• The filing lists 12 separate lots ranging from 1,200 to 106,718 shares at per-share prices reported between $231.12 and $243.50 in the itemized entries; the footnotes show transaction price ranges across the lots from $230.67 to $243.72.

Key details

• Transaction date: Oct 5, 2026. Itemized sales (shares @ price = proceeds):
  • 16,220 @ $231.12 = $3,748,766
  • 61,210 @ $232.37 = $14,223,368
  • 56,426 @ $233.19 = $13,157,979
  • 48,845 @ $234.21 = $11,439,987
  • 106,718 @ $235.24 = $25,104,342
  • 73,588 @ $235.99 = $17,366,032
  • 18,224 @ $237.15 = $4,321,822
  • 48,655 @ $238.22 = $11,590,594
  • 48,061 @ $239.23 = $11,497,633
  • 14,853 @ $240.00 = $3,564,720
  • 1,200 @ $241.02 = $289,224
  • 6,000 @ $243.50 = $1,461,000
• Shares owned after the transaction: not stated in the information provided.
• Footnotes: the filing shows weighted-average prices per lot with specified price ranges for each lot (overall ranges $230.67 to $243.72) and the reporting person offers to provide per-price breakdowns on request.
• Plan and holdings: the sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 22, 2026, and the shares sold represent settled restricted share units constituting approximately 17% of the reporting person's granted equity. The filing states no further sales will be made under that plan.
• Regulatory note: the filing states the issuer is a foreign private issuer under Rule 3a12-3(b), so the reporting person's transactions are exempt from Sections 16(b) and 16(c) of the Act.
• Filing timing: Form 4 was filed Oct 6, 2026, reporting transactions on Oct 5, 2026.

Why it may matter

• The filing says the sales were made under a Rule 10b5-1 plan and involved settled restricted share units (not an option exercise or a gift).
• The filing states the sold shares represent about 17% of the reporting person's granted equity.
• This filing does not show why the insider traded or why the company acted.